India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
The funding will accelerate Sinopia’s data-driven drug discovery efforts
Astal estimates the collaboration will generate incremental revenue of approximately Rs. 300 crore upon implementation
Lucid-MS represents a potential breakthrough in the treatment of multiple sclerosis
The drug, currently in a phase 1b/2 clinical trial for small cell lung cancer, is a polymer nanoparticle formulation of SN-38
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The study found that nerandomilast effectively slowed lung function decline in patients, with discontinuation rates similar to placebo
Subscribe To Our Newsletter & Stay Updated
